Login to Your Account



Boston-bound Vesalius raises $72M in first close of new fund

By Cormac Sheridan
Staff Writer

Thursday, May 18, 2017

DUBLIN – Vesalius Biocapital Partners Sàrl has responded to Boston's gravitational pull by putting in place a plan to establish a presence in the world's foremost biotech hub as it raises €150 million (US$166.7 million) for its third fund, Vesalius Biocapital III (VBC III).

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription